Genetic Control of Serum Marinobufagenin in the Spontaneously Hypertensive Rat and the Relationship to Blood Pressure
BackgroundWe have investigated serum levels of immunoreactive marinobufagenin (MBG) in 16‐ to 20‐week‐old spontaneously hypertensive rats (SHRs)‐A3 and in the normotensive Wistar‐Kyoto (WKY) rat strain in the absence of salt loading, and we have investigated the genetic control of serum MBG. Methods...
Main Authors: | Renata I. Dmitrieva, Stacy M. Cranford, Peter A. Doris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-10-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.117.006704 |
Similar Items
-
Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia
by: Natalia I. Agalakova, et al.
Published: (2022-03-01) -
Endogenous Mammalian Cardiotonic Steroids—A New Cardiovascular Risk Factor?—A Mini-Review
by: Natalia Słabiak-Błaż, et al.
Published: (2021-07-01) -
Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis
by: Natalia I. Agalakova, et al.
Published: (2021-02-01) -
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study
by: Davide Bolignano, et al.
Published: (2023-07-01) -
Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling‐mediated mitochondrial apoptotic pathway
by: Yu‐Long Lan, et al.
Published: (2018-05-01)